FundedIQ
Biotechnology

Unchained Labs: Funding, Investors & Team (Oct 2026)

Unchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it. It offers a multiplex protein stability platform for biologics that measures a host of protein stability parameters. The company's products include protein sizing systems, stability quantifiers, benchtop workflow solutions, automated buffer exchanges, concentration liberators, particle identifiers, and more, enabling biologics researchers to speed up their work with ease. Unchained Labs was established in 2013 and is based in Pleasanton, California, USA.

www.unchainedlabs.com LinkedIn Pleasanton, United States 101-250 employees
Biotechnology Medical Device Product Research
Total raised
$155M
Rounds
1
Latest
Debt Financing
Aug 2021

Unchained Labs has raised $155M across 1 funding round on record, the most recent a Debt Financing of $155M announced in Aug 2021.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Unchained Labs Company Profile and Key Stats

Total funding raised
$155M
across 1 round on record
Funding rounds on record
1
Latest funding round
Debt Financing
$155M in Aug 2021
Employees
101-250
reported band
Headquarters
Pleasanton, United States

Latest funding round on record: Aug 2021.

Unchained Labs Funding Rounds

Date
Round
Amount
Debt Financing
$155M

Unchained Labs Founders and Leadership Team

Name
Role
Contact
Tim Harkness
CEO
Locked

Contact details for the Unchained Labs team: 1 of 1 has an email address on file.

Start 14-day free trial →

Unchained Labs Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Unchained Labs' latest round of $155M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Unchained Labs in Biotechnology and Pleasanton

Companies Similar to Unchained Labs

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Unchained Labs Funding FAQs

What does Unchained Labs do?

Unchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it. It offers a multiplex protein stability platform for biologics that measures a host of protein stability parameters. The company's products include protein sizing systems, stability quantifiers, benchtop workflow solutions, automated buffer exchanges, concentration liberators, particle identifiers, and more, enabling biologics researchers to speed up their work with ease. Unchained Labs was established in 2013 and is based in Pleasanton, California, USA.

How much funding has Unchained Labs raised?

Unchained Labs has raised $155M across 1 round on record. The most recent is a Debt Financing of $155M announced in Aug 2021.

When did Unchained Labs last raise funding?

Unchained Labs' most recent funding round on record is a Debt Financing of $155M, announced in Aug 2021.

Who is the CEO of Unchained Labs?

Tim Harkness is listed as CEO at Unchained Labs.

Where is Unchained Labs headquartered?

Unchained Labs is based in Pleasanton, California, United States.

How many employees does Unchained Labs have?

Unchained Labs is in the 101-250 employee band.

How does Unchained Labs' funding compare to other Biotechnology startups?

Unchained Labs' latest round of $155M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Unchained Labs Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Unchained Labs is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.